G. Brandenberger et al., PARATHYROID FUNCTION IN CARDIAC TRANSPLANT PATIENTS - EVALUATION DURING PHYSICAL EXERCISE, European journal of applied physiology and occupational physiology, 70(5), 1995, pp. 401-406
The survival rate of heart transplant patients has increased considera
bly since the development of new immunosuppressive drugs. In the long
term, however, cardiac transplantation results in a high incidence of
osteoporosis which represents a major functional handicap. To examine
whether patients in the early stages have impaired phosphocalcic metab
olism, intact parathyroid hormone (PTH 1-84), native osteocalcin, ioni
zed Ca++ and pH were measured at rest and during muscular exercises a
dynamic test used to override circadian and ultradian PTH variations.
A group of 12 patients receiving the usual immunosuppressive therapy,
which is mainly an association of cyclosporin and prednisolone, and 8
sedentary control subjects performed a square-wave endurance test at t
he same relative intensity for 30 min. No patient had previous bone di
sease and the period since transplantation was 12.2 +/- 2.7 months. Fo
r the transplant patients, initial PTH concentrations and responses to
exercise were higher (P < 0.01) compared to the control subjects with
a dramatic increase after 10 min of recovery. From higher (P < 0.001)
resting concentrations, osteocalcin further increased during exercise
(P < 0.01) in the heart transplant group but not in the control subje
cts. In both groups pH showed the same time-course with a rapid fall d
uring exercise (P < 0.05) and Ca++ concentrations increased during the
exercise period. (P < 0.01 for patients; P < 0.05 for controls) with
a significant fall in both groups after 10 min of recovery (P < 0.01).
Despite a tendency for initial Ca++ concentrations to be lower in the
patients (P < 0.07), there were no significant differences between bo
th groups either for pH or for Ca++. These results show that in the ea
rly stage of transplantation, the patients under immunosuppressive the
rapy have moderate hyperparathyroidism which precedes the serious comp
lications of bone loss in long-term transplant patients.